Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 47 peer-reviewed journal articles Updated
Cardiology

Giant Cell Myocarditis: A Patient Guide

At a Glance

Giant cell myocarditis is a rare autoimmune attack on the heart that can worsen quickly. Diagnosis often relies on a heart-tissue biopsy, while urgent combination immune-suppressing treatment and specialist support may prevent further damage; some patients need mechanical heart support or a transplant.

Safety Warning: This guide is for informational purposes and cannot diagnose Giant Cell Myocarditis. If you or a loved one are experiencing new severe chest pain, fainting, extreme breathlessness, confusion, blue-tinged lips, or a rapidly worsening heartbeat, call emergency services immediately.

Giant Cell Myocarditis (GCM) is an exceptionally rare and aggressive autoimmune disease that requires urgent medical attention. Unlike more common forms of heart inflammation, GCM occurs when the body’s own immune system launches a rapid and intense attack on the heart muscle, causing widespread damage that can lead to sudden heart failure or life-threatening heart rhythms [1][2]. Because the disease can progress with alarming speed—sometimes changing a patient’s condition over the course of hours—recognizing the emergency and seeking immediate, specialized care is the most critical first step [3][4].

The defining feature of this condition is the presence of “giant cells”—large, abnormal immune units that form when white blood cells fuse together and are found alongside destroyed healthy heart tissue [5][6]. Because GCM can mimic other conditions like a heart attack or less severe forms of myocarditis, an endomyocardial biopsy (taking a tiny sample of heart tissue) is the reference diagnostic standard for an accurate diagnosis [7][8]. Identifying the characteristic giant cells early allows doctors to start the intensive treatments needed to stop the immune system’s attack before the damage becomes irreversible [9][10]. However, specialists may make urgent treatment and support decisions while pathology and other tests are still being evaluated, especially if the patient is unstable.

Once diagnosed, the care involves specialist-directed combination immunosuppression, which typically uses a combination of powerful medications to suppress the autoimmune response [1][11]. In many cases, the heart may be too weak to pump effectively on its own while these medications take effect, requiring the use of mechanical support machines—such as ECMO or VADs—to act as a bridge to recovery or toward a transplant [12][13]. These treatments are complex and carry significant risks, meaning they must be managed by experts who are familiar with the unique demands of GCM [4][14].

Living with GCM requires a long-term partnership with an Advanced Heart Failure and Transplant Center [13]. While many patients respond well to initial treatment, some will ultimately require a heart transplant if the muscle damage is too severe [15]. Even after a transplant or successful stabilization, the condition requires ongoing, individualized monitoring because of the risk of the disease returning or the immune system reacting to a new heart [16][17]. Though the journey is intense, specialized care and modern medicine have significantly improved the outlook for survivors, providing a path toward long-term recovery and health [15][8].

In this guide

6 chapters

01

Understanding Giant Cell Myocarditis

Learn what giant cell myocarditis is, how biopsy confirms it, why combination immunosuppression is urgent, and when mechanical support or transplant is needed.

02

Warning Signs and Emergencies

Learn the emergency warning signs of giant cell myocarditis, including shock, dangerous heart rhythms, heart block, severe breathlessness, and when to call 911.

03

Getting an Accurate Diagnosis (The Heart Biopsy)

Learn how giant cell myocarditis is diagnosed with a heart biopsy, including sampling error, pathology findings, procedure risks, and cardiac sarcoidosis.

04

Immediate Treatment and Mechanical Support

Learn how giant cell myocarditis is treated with immunosuppressants, VA-ECMO, Impella, or VAD support, and why advanced heart failure centers are important.

05

Heart Transplant and Recurrence Risk

Learn about heart transplant outcomes for giant cell myocarditis, including survival, rejection, recurrence, warning signs, biopsies, and lifelong monitoring.

06

Long-Term Management and Monitoring

Learn how giant cell myocarditis is monitored over time, including immune-suppressing medicines, heart tests, transplant follow-up, and medication safety.

Common questions in this guide

What is giant cell myocarditis, and why is it dangerous?
Giant cell myocarditis is a rare autoimmune disease in which the immune system attacks the heart muscle. It can worsen rapidly and lead to heart failure or dangerous heart rhythms, so suspected cases need urgent specialist care.
How do doctors confirm giant cell myocarditis?
Doctors often use an endomyocardial biopsy, which removes a tiny sample of heart muscle for examination, as the reference test. Other tests and the patient's condition are also considered, and urgent treatment or heart support may begin while results are being reviewed.
What if the heart biopsy is negative but GCM is still suspected?
A negative biopsy may not end the evaluation when doctors still strongly suspect giant cell myocarditis. The specialist team may review all findings, consider additional or repeat testing, and make urgent treatment or support decisions while pathology and other results are assessed.
How is giant cell myocarditis treated?
Treatment usually involves a specialist-directed combination of immune-suppressing medicines to slow the attack on the heart. If the heart cannot pump well enough, ECMO or a ventricular assist device may provide temporary mechanical support while the team works toward recovery or transplant.
When might a heart transplant be needed for GCM?
A transplant may be considered when giant cell myocarditis has caused severe, lasting heart-muscle damage and the heart cannot recover enough to support the body. ECMO or a ventricular assist device may be used as a bridge while the transplant team evaluates the next step.
Can giant cell myocarditis return after treatment or transplant?
Giant cell myocarditis can require long-term, individualized monitoring because the disease may return. After a transplant, doctors also watch for the immune system reacting to the new heart and adjust treatment as needed.
Which symptoms of giant cell myocarditis require emergency help?
Call emergency services for new severe chest pain, fainting, extreme shortness of breath, confusion, blue-tinged lips, or a rapidly worsening heartbeat. Giant cell myocarditis can change quickly, and early emergency assessment is important.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms and tests, how quickly do we need to consider a biopsy to confirm GCM?
  2. 2.Does this hospital have an advanced heart failure team and the ability to provide mechanical heart support if I need it?
  3. 3.If my biopsy is negative but you still suspect GCM, what are the next steps to ensure we don't miss the diagnosis?
  4. 4.What is the long-term plan for my immunosuppression, and how will we monitor for a potential relapse or recurrence?
  5. 5.At what point should we begin discussing the possibility of a heart transplant?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Giant cell myocarditis: from immune pathogenesis to contemporary management.

    Vosko I, Wallner M

    Heart failure reviews 2026; (31(1)).

    PMID: 42624936
  2. 2

    Diagnosis and Treatment of Acute Myocarditis: A Review.

    Ammirati E, Moslehi JJ

    JAMA 2023; (329(13)):1098-1113 doi:10.1001/jama.2023.3371.

    PMID: 37014337
  3. 3

    Giant Cell Myocarditis: Not Always a Presentation of Cardiogenic Shock.

    Tompkins R, Cole WJ, Rosenzweig BP, et al.

    Case reports in cardiology 2015; (2015()):173826 doi:10.1155/2015/173826.

    PMID: 26257963
  4. 4

    Giant cell myositis and myocarditis revisited.

    Oflazer P

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):302-306 doi:10.36185/2532-1900-033.

    PMID: 33458585
  5. 5

    Fulminant lymphocytic myocarditis with unusual giant cell detection: a case report.

    Sato T, Ikeda Y, Seguchi O, et al.

    European heart journal. Case reports 2025; (9(6)):ytaf248 doi:10.1093/ehjcr/ytaf248.

    PMID: 40463353
  6. 6

    A Tale of Two Myocarditides: Giant Cell Myocarditis and Sarcoidosis-A Pathologist's Review.

    Maleszewski JJ

    Archives of pathology & laboratory medicine 2025; (150(1)):44-49 doi:10.5858/arpa.2025-0287-RA.

    PMID: 41435868
  7. 7

    [Endomyocardial biopsy should be performed in selected patients with suspected myocarditis].

    Ammirati E, Cipriani M, Bonacina E, et al.

    Giornale italiano di cardiologia (2006) 2015; (16(10)):539-43 doi:10.1714/2028.22034.

    PMID: 26444211
  8. 8

    A case report of giant cell myocarditis complicated by severe heart failure: the value of early endomyocardial biopsy and mechanical circulatory support.

    Lunde T, Gude E, Myrmel GMS, et al.

    Cardiovascular diagnosis and therapy 2023; (13(6)):1136-1146 doi:10.21037/cdt-23-265.

    PMID: 38162107
  9. 9

    Giant Cell Myocarditis: An Updated Review of Pathogenesis, Clinical Presentation, and Modern Management Approaches.

    Elattar S, Hassid Y, Cheikhali R, et al.

    Cardiology in review 2025; doi:10.1097/CRD.0000000000001123.

    PMID: 41198092
  10. 10

    Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study.

    Schmidt M, Ponnaiah M, Huang F, et al.

    Intensive care medicine 2026; (52(2)):240-251 doi:10.1007/s00134-025-08268-3.

    PMID: 41524796
  11. 11

    Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week.

    Bang V, Ganatra S, Shah SP, et al.

    Journal of the American College of Cardiology 2021; (77(8)):1122-1134 doi:10.1016/j.jacc.2020.11.074.

    PMID: 33632487
  12. 12

    Outcomes of Mechanical Circulatory Support for Giant Cell Myocarditis: A Systematic Review.

    Patel PM, Saxena A, Wood CT, et al.

    Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9123905.

    PMID: 33271929
  13. 13

    Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort.

    Montero S, Aissaoui N, Tadié JM, et al.

    International journal of cardiology 2018; (253()):105-112 doi:10.1016/j.ijcard.2017.10.053.

    PMID: 29306448
  14. 14

    Usefulness of Rabbit Anti-thymocyte Globulin in Patients With Giant Cell Myocarditis.

    Suarez-Barrientos A, Wong J, Bell A, et al.

    The American journal of cardiology 2015; (116(3)):447-51.

    PMID: 26048854
  15. 15

    Heart Transplantation in Giant Cell Myocarditis: Analysis of the United Network for Organ Sharing Registry.

    Elamm CA, Al-Kindi SG, Bianco CM, et al.

    Journal of cardiac failure 2017; (23(7)):566-569 doi:10.1016/j.cardfail.2017.04.015.

    PMID: 28449952
  16. 16

    Heart Transplantation for Giant Cell Myocarditis: A Case Series.

    Vaidya GN, Czer LSC, Luthringer D, et al.

    Transplantation proceedings 2021; (53(1)):348-352 doi:10.1016/j.transproceed.2020.10.047.

    PMID: 33384178
  17. 17

    Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis.

    Bobbio E, Björkenstam M, Nwaru BI, et al.

    Clinical research in cardiology : official journal of the German Cardiac Society 2022; (111(2)):125-140 doi:10.1007/s00392-021-01920-0.

    PMID: 34402927

This guide is for informational purposes only and does not constitute medical advice or diagnose giant cell myocarditis. Suspected GCM can worsen rapidly; seek emergency care for severe or rapidly worsening symptoms and follow your specialist's advice.

Get notified when new evidence is published on Giant cell myocarditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.